Avidity Biosciences's total assets for Q4 2024 were $1.56B, a decrease of -4.69% from the previous quarter. RNA total liabilities were $138.94M for the fiscal quarter, a 1.12% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.